{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027834",
    "licUnit": "1",
    "validDate": "2030-03-10 00:00:00.000",
    "issueDate": "2020-03-10 00:00:00.000",
    "oriIssueDate": "2020-03-10",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA05202783404",
    "prodNameC": "他扎羅汀",
    "prodNameE": "Tazarotene",
    "indicationsName": [
        "乾癬及尋常性痤瘡。"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "4F"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "B19A0161-D9FF-4270-AF11-98450971B79B",
    "subCategory": [],
    "ingredientsDesc": [
        "Tazarotene contains not less than 98.0% and not more than 102.0% of C21H21NO2S, calculated on the dried basis."
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "新雙隆生技股份有限公司",
    "applicantAddr": "台北市松山區復興北路369號14樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "F5642759-657A-413A-931E-71DCC0FCD792",
            "factoryCode": "1",
            "factoryName": "PCAS FINLAND OY",
            "factoryAddr": "MESSUKENTANKATU 8, 20210 TURKU, FINLAND",
            "factoryCompanyAddr": "",
            "countryCode": "FI",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FFI0022100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "Tazarotene contains not less than 98.0% and not more than 102.0% of C21H21NO2S, calculated on the dried basis.",
            "ingredientsDesc": "Tazarotene contains not less than 98.0% and not more than 102.0% of C21H21NO2S, calculated on the dried basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "D05AX05"
        }
    ],
    "licBaseId": "CF5ED2B4-ADBA-47A3-B923-C4A8A4915CF0"
}